Advisory Services Network’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Advisory Services Network’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-80	Closed	-$269	–	3790
2023 Q4	$269	Sell	80 -257,191	-100%	-$663K	﹤0.01%	3697
2023 Q3	$612K	Hold	257,271	–	–	0.02%	823
2023 Q2	$453K	Hold	257,271	–	–	0.01%	960
2023 Q1	$792K	Sell	257,271 -8,000	-3%	-$47.9K	0.02%	701
2022 Q4	$1.41M	Buy	265,271 +2,000	+0.8%	+$9.14K	0.04%	488
2022 Q3	$929K	Buy	263,271 +3,700	+1%	+$12.2K	0.03%	567
2022 Q2	$670K	Buy	259,571 +80	+0%	+$222	0.02%	707
2022 Q1	$1.16M	Hold	259,491	–	–	0.03%	580
2021 Q4	$1.77M	Sell	259,491 -8,799	-3%	-$59.9K	0.05%	442
2021 Q3	$1.96M	Buy	268,290 +11,518	+4%	+$98.8K	0.06%	385
2021 Q2	$2.57M	Buy	256,772 +1	+0%	+$9	0.08%	316
2021 Q1	$2.45M	Buy	+256,771	New	+$2.52M	0.09%	291

Other funds holding PSTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Advisory Services Network's PSTX Position: Q1 2024 in Review

Advisory Services Network sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2024, closing a stake of 80 shares — an estimated $269 sold.

Advisory Services Network first reported a position in PSTX in Q1 2021 and held it in 12 quarters. The position peaked at $2.57M in Q2 2021. 91 funds tracked by Wall St. Rank hold PSTX as of Q1 2024.

Advisory Services Network reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 80 Poseida Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $269.
Advisory Services Network first reported a position in Poseida Therapeutics, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
Advisory Services Network's Poseida Therapeutics, Inc. Common Stock position peaked at $2.57M in Q2 2021.
91 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.